Answers are grounded in this paper and cite their sources.
Identifying donors with latent infection and a history of viral hepatitis, followed by their exclusion from donation, is one method for harvesting virus-safe blood components and, consequently, minimizing the risk of post-transfusion complications. To this end, an analysis of the results of a study on antibodies to the hepatitis B core antigen (anti-HBcore) was conducted in donors at the Sakha Republic (Yakutia) Blood Transfusion Center in 2021-2024. During the entire study period the overall detection rate of anti-HBcore was 26.3%, with no statistically significant gender-based difference (25.3% in men vs. 28.2% in women; p = 0.912). Donor age appeared to be one of the main factors influencing anti-HBcore prevalence: the lowest frequency of anti-HBcore was observed in the 21-30 age group – 3.8%, in the 41-50 age group – 58.8%, and in the group over 50 years – 41.0%. Based on the analysis of the obtained results, it is proposed to determine anti-HBcore with each donation for donors over 30-35 years of age.
No takes yet. Share an insight, caveat, or question.
Vv et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: